---
figid: PMC9286858__ECI-52-0-g001
pmcid: PMC9286858
image_filename: ECI-52-0-g001.jpg
figure_link: /pmc/articles/PMC9286858/figure/eci13751-fig-0003/
number: FIGURE 3
figure_title: ''
caption: Forest plot showing the effects of 4S‐AF scheme characterization or ABC pathway
  compliance (group 2) and 4S‐AF scheme characterization plus ABC adherent management
  (group 3) on the composite outcome of all‐cause death/any thromboembolic event;
  all‐cause death; any thromboembolic event and major bleeding. Odds ratios are adjusted
  for age, gender, chronic kidney disease, chronic obstructive pulmonary disease,
  coronary artery disease, diabetes mellitus, heart failure, hypercholesterolaemia,
  hypertension and prior stroke. aOR, adjusted odds ratio; CI, confidence interval;
  TE, thromboembolism
article_title: 4S‐AF scheme and ABC pathway guided management improves outcomes in
  atrial fibrillation patients.
citation: Yutao Guo, et al. Eur J Clin Invest. 2022 Jun;52(6):e13751.
year: '2022'

doi: 10.1111/eci.13751
journal_title: European Journal of Clinical Investigation
journal_nlm_ta: Eur J Clin Invest
publisher_name: John Wiley and Sons Inc.

keywords:
- 4S‐AF scheme
- ABC pathway
- atrial fibrillation
- guidelines

---
